Financial News
Mainz Biomed N.V. - Ordinary Shares (NQ: MYNZ )
0.3590
+0.0118
(+3.40%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Headline News about Mainz Biomed N.V. - Ordinary Shares
![](https://public.newsdirect.com/224803617/V6lJq577.png)
![](https://cdn.benzinga.com/files/equipment-researchers.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-stock-market.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/07/09/movers-image.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/07/08/Movers.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/laboratory-supplies-medical-work.jpg?width=1200&height=800&fit=crop)
![](https://public.newsdirect.com/913462543/h9huxakk.png)
![](https://public.newsdirect.com/211982546/n7Qmwz2w.png)
![](https://cdn.benzinga.com/files/covid-recovery-center-female-doctor-holding-older-patient-s-hands_2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/05/29/Movers.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/05/wall-street-morning.jpg)
![](https://investorplace.com/wp-content/uploads/2021/05/wall-street-morning.jpg)
![](https://cdn.benzinga.com/files/front-view-doctor-holding-tubes.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/3d-render-medical-background-with-microscopic-view-abstract-virus-cell_1048-13421.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/covid-recovery-center-female-doctor-holding-older-patient-s-hands_1.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/covid-recovery-center-female-doctor-holding-older-patient-s-hands_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/front-view-doctor-holding-anatomic-model.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/close-up-hand-holding-purple-ribbon-with-stethoscope.jpg?width=1200&height=800&fit=crop)
Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment
February 22, 2024
Via Benzinga
Topics
Intellectual Property
![](https://cdn.benzinga.com/files/front-view-doctor-holding-tubes_0.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/3d-medical-background-with-virus-cells-dna-strand.jpg?width=1200&height=800&fit=crop)
Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The Saddle
February 01, 2024
Via Benzinga
Exposures
COVID-19
![](https://cdn.benzinga.com/files/images/story/2024/02/01/screenshot_2024-02-01_at_6.29.31_pm.png?width=1200&height=800&fit=crop)
2 Million Cancer Diagnoses And 600,000 Cancer Deaths Expected In 2024 – Prevention Is Key To Treatment, And Mainz Biomed Is Leading The Charge
February 01, 2024
Via Benzinga
Topics
Death
Exposures
Death
![](https://cdn.benzinga.com/files/medical-banner-with-doctor-wearing-equipment.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/7774_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/Genetic-Research-And-Biotech-Science-Con_0.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.